BASAGLAR 100 UI/ML SOL INJ CT 5 CARP VD INC X 3 ML

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1126001940037
  • GGREM 507617090020207
  • Código de barras 7896382707681

O que a fonte publica

Detentor do registro
ELI LILLY DO BRASIL LTDA
Princípios ativos
INSULINA GLARGINA
Embalagem
100 UI/ML SOL INJ CT 5 CARP VD INC X 3 ML
Tipo de produto
Biológico
Classe terapêutica
A10C5 - Insulinas humanas e análogos, ação longa

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:507617090020207
{
  "name": "BASAGLAR 100 UI/ML SOL INJ CT 5 CARP VD INC X 3 ML",
  "holder": "ELI LILLY DO BRASIL LTDA",
  "stripe": null,
  "barcodes": [
    "7896382707681"
  ],
  "confaz87": true,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "507617090020207",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "43.940.618/0001-44",
  "priceRegime": "Regulado",
  "productName": "BASAGLAR",
  "productType": "Biológico",
  "hospitalOnly": false,
  "presentation": "100 UI/ML SOL INJ CT 5 CARP VD INC X 3 ML",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "184.93",
    "icms-12": "210.15",
    "icms-17": "222.81",
    "icms-18": "225.52",
    "icms-19": "228.31",
    "icms-20": "231.16",
    "icms-21": "234.09",
    "icms-22": "237.09",
    "icms-23": "240.17",
    "icms-17.5": "224.16",
    "icms-19.5": "229.73",
    "icms-20.5": "232.62",
    "icms-22.5": "238.62",
    "icms-12-alc": "207.63",
    "icms-17-alc": "220.13",
    "icms-18-alc": "222.82",
    "icms-19-alc": "225.57",
    "icms-20-alc": "228.39",
    "icms-21-alc": "231.28",
    "icms-22-alc": "234.24",
    "icms-23-alc": "237.29",
    "withoutTaxes": "182.71",
    "icms-17.5-alc": "221.47",
    "icms-19.5-alc": "226.97",
    "icms-20.5-alc": "229.82",
    "icms-22.5-alc": "235.76"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "INSULINA GLARGINA",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "254.91",
    "icms-12": "289.67",
    "icms-17": "307.12",
    "icms-18": "310.86",
    "icms-19": "314.70",
    "icms-20": "318.63",
    "icms-21": "322.67",
    "icms-22": "326.80",
    "icms-23": "331.05",
    "icms-17.5": "308.98",
    "icms-19.5": "316.66",
    "icms-20.5": "320.64",
    "icms-22.5": "328.91",
    "icms-12-alc": "287.04",
    "icms-17-alc": "304.32",
    "icms-18-alc": "308.04",
    "icms-19-alc": "311.84",
    "icms-20-alc": "315.74",
    "icms-21-alc": "319.73",
    "icms-22-alc": "323.82",
    "icms-23-alc": "328.04",
    "withoutTaxes": "252.59",
    "icms-17.5-alc": "306.17",
    "icms-19.5-alc": "313.77",
    "icms-20.5-alc": "317.71",
    "icms-22.5-alc": "325.92"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "INSULINA GLARGINA"
  ],
  "therapeuticClass": "A10C5 - Insulinas humanas e análogos, ação longa",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1126001940037",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "A10C5",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:507617090020207"